BACKGROUND: Neuropathy is a common complication of diabetic patients. AIM: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabetic patients attended at a family medicine unit. MATERIAL AND METHODS: Cross-sectional assessment of 348 type 2 diabetic patients aged 34-89 years (60% females) with a disease duration of 5 to 15 years. Peripheral neurological status was evaluated using The Michigan Neuropathy Screening Instrument, a tool that includes a self-assessment of symptoms and a physical examination. RESULTS: Diabetic neuropathy was found in 240 patients (69%). The prevalence in males and females was 72 and 67% respectively. The prevalence in patients with a disease duration of 5, 10 and 15 years, was 59, 69 and 77%, respectively. Fifty percent of patients with neuropathy complained of dry skin, 2% had ulcers, 43% had an abnormal perception of vibration and 29% had an abnormal monofilament test. CONCLUSIONS: The overall prevalence of peripheral neuropathy in this group of patients was 69% and was directly associated with the duration of the disease.
BACKGROUND:Neuropathy is a common complication of diabeticpatients. AIM: To determine the prevalence of diabetic peripheral neuropathy in Type 2 diabeticpatients attended at a family medicine unit. MATERIAL AND METHODS: Cross-sectional assessment of 348 type 2 diabeticpatients aged 34-89 years (60% females) with a disease duration of 5 to 15 years. Peripheral neurological status was evaluated using The Michigan Neuropathy Screening Instrument, a tool that includes a self-assessment of symptoms and a physical examination. RESULTS:Diabetic neuropathy was found in 240 patients (69%). The prevalence in males and females was 72 and 67% respectively. The prevalence in patients with a disease duration of 5, 10 and 15 years, was 59, 69 and 77%, respectively. Fifty percent of patients with neuropathy complained of dry skin, 2% had ulcers, 43% had an abnormal perception of vibration and 29% had an abnormal monofilament test. CONCLUSIONS: The overall prevalence of peripheral neuropathy in this group of patients was 69% and was directly associated with the duration of the disease.
Authors: María de Los Angeles Lazo; Antonio Bernabé-Ortiz; Miguel E Pinto; Ray Ticse; German Malaga; Katherine Sacksteder; J Jaime Miranda; Robert H Gilman Journal: PLoS One Date: 2014-05-01 Impact factor: 3.240
Authors: Luis Miguel Román-Pintos; Geannyne Villegas-Rivera; Adolfo Daniel Rodríguez-Carrizalez; Alejandra Guillermina Miranda-Díaz; Ernesto Germán Cardona-Muñoz Journal: J Diabetes Res Date: 2016-12-12 Impact factor: 4.011
Authors: Surendra Darivemula; Khadervali Nagoor; Shakeer Khan Patan; N Bayapa Reddy; C Sravana Deepthi; Chandra Sekhar Chittooru Journal: Indian J Community Med Date: 2019 Apr-Jun
Authors: Aswathy Sreedevi; Vijayakumar Krishnapillai; Vishnu B Menon; Minu Maria Mathew; Rajeesh R Nair; Gopal S Pillai; Mathews Numpelil; Jaideep Menon; Vishal Marwaha Journal: Front Public Health Date: 2022-02-03